Antiviral Agents
Journal of critical and intensive care (Online), vol.11, no.1, pp.27-29, 2020 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Review
- Volume: 11 Issue: 1
- Publication Date: 2020
- Doi Number: 10.37678/dcybd.2020.2380
- Journal Name: Journal of critical and intensive care (Online)
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.27-29
- Çukurova University Affiliated: Yes
Abstract
Coronavirus disease 2019 (COVID-19) is a respiratory track infection which caused a pandemia after beingrecognized in Wuhan, China at the end of 2019. While most people with COVID-19 develop mild oruncomplicated illness, approximately 14 % develop severe disase requiring hospitalization and oxygen supportand 5 % require intensive care unit admission. Currently, there is no proven reliable and effective antiviralagent for COVID-19 pneumonia however, more than 100 randomised controlled clinical trials are ongoing.This paper will discuss the antiviral treatments in the critically ill patients with COVID-19 pneumonia.